Depreciation of Guardant Health, Inc. from 30 Sep 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Guardant Health, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Sep 2017 to 31 Dec 2025.
  • Guardant Health, Inc. Depreciation for the quarter ending 31 Dec 2025 was $9,700,000, a 2% decline year-over-year.
  • Guardant Health, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $38,100,000, a 5% decline year-over-year.
  • Guardant Health, Inc. annual Depreciation for 2025 was $38,100,000, a 5% decline from 2024.
  • Guardant Health, Inc. annual Depreciation for 2024 was $40,100,000, a 0.25% increase from 2023.
  • Guardant Health, Inc. annual Depreciation for 2023 was $40,000,000, a 20% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Guardant Health, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $38,100,000 $9,700,000 -$200,000 -2% 01 Oct 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $38,300,000 $9,000,000 -$1,100,000 -11% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $39,400,000 $9,600,000 -$500,000 -5% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $39,900,000 $9,800,000 -$200,000 -2% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $40,100,000 $9,900,000 -$300,000 -2.9% 01 Oct 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $40,400,000 $10,100,000 -$200,000 -1.9% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025 2025 Q3
Q2 2024 $40,600,000 $10,100,000 +$200,000 +2% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2
Q1 2024 $40,400,000 $10,000,000 +$400,000 +4.2% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q4 2023 $40,000,000 $10,200,000 +$700,000 +7.4% 01 Oct 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
Q3 2023 $39,300,000 $10,300,000 +$1,200,000 +13% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $38,100,000 $9,900,000 +$1,800,000 +22% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $36,300,000 $9,600,000 +$2,900,000 +43% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $33,400,000 $9,500,000 +$3,900,000 +70% 01 Oct 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
Q3 2022 $29,500,000 $9,100,000 +$4,100,000 +82% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $25,400,000 $8,100,000 +$3,000,000 +59% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $22,400,000 $6,700,000 +$2,200,000 +49% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $20,200,000 $5,600,000 +$1,500,000 +37% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $18,700,000 $5,000,000 +$1,200,000 +32% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $17,500,000 $5,100,000 +$1,900,000 +59% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $15,600,000 $4,500,000 +$1,500,000 +50% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $14,100,000 $4,100,000 +$1,600,000 +64% 01 Oct 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q3 2020 $12,500,000 $3,800,000 +$1,300,000 +52% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $11,200,000 $3,200,000 +$1,000,000 +45% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $10,200,000 $3,000,000 +$900,000 +43% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $9,300,000 $2,500,000 -$3,600,000 -59% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $12,900,000 $2,500,000 +$800,000 +47% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $12,100,000 $2,200,000 +$900,000 +69% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $11,200,000 $2,100,000 +$900,000 +75% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $10,300,000 $6,100,000 01 Oct 2018 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $1,700,000 +$600,000 +55% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $1,300,000 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $1,200,000 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q3 2017 $1,100,000 01 Jul 2017 30 Sep 2017 10-Q 19 Nov 2018 2018 Q3

Guardant Health, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $38,100,000 -$2,000,000 -5% 01 Jan 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
2024 $40,100,000 +$100,000 +0.25% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
2023 $40,000,000 +$6,600,000 +20% 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
2022 $33,400,000 +$13,200,000 +65% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
2021 $20,200,000 +$6,100,000 +43% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $14,100,000 +$4,800,000 +52% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $9,300,000 +$3,200,000 +52% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $6,100,000 +$1,900,000 +45% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $4,200,000 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.